Barbara Valsasina
Inventor
Stats
- 6 US patents issued
- 7 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 6 US Patents Issued
- 7 US Applications Filed
- 96 Total Citation Count
- Nov 4, 2022 Most Recent Filing
- Dec 17, 2007 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| NERVIANO MEDICAL SCIENCES S.R.L. | 2
2 2 2 1 | 2007
2008 2009 2010 2014 |
| Genentech, Inc. | 2
1 2 | 2009
2012 2014 |
Inventor Addresses
| Address | Duration |
|---|---|
| Milan, IT | Feb 11, 10 - Jan 16, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 6 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0018,051 | 2025 | ANTHRACYCLINE DERIVATIVE LINKER REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS | 0 |
| 9695240 | 2017 | Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds | 8 |
| 2015/0051,380 | 2015 | ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS | 1 |
| 8927530 | 2015 | Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent | 3 |
| 8900589 | 2014 | Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds | 18 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.